Hyperinsulinaemic hypoglycaemia:genetic mechanisms, diagnosis and management

Zainaba Mohamed1, Ved Bhushan Arya, Khalid Hussain

  • 1University College London, Institue of Child Health, Developmental Endocrinology Research Clinical, Molecular Genetics Unit, London, United Kingdom.

Insights

Hyperinsulinaemic hypoglycaemia (HH) involves unregulated insulin secretion, potentially causing severe infant brain injury. Early diagnosis and management of congenital hyperinsulinism (CHI) are crucial for preventing neurological damage.

Area of Science:

  • Endocrinology
  • Genetics
  • Pediatrics

Background:

  • Hyperinsulinaemic hypoglycaemia (HH) is a condition of unregulated insulin secretion from pancreatic beta-cells.
  • Untreated hypoglycaemia in infants can cause seizures, developmental delay, and permanent brain injury.
  • Congenital hyperinsulinism (CHI) is a severe form of HH with genetic origins.

Purpose of the Study:

  • To review the molecular basis of CHI.
  • To outline clinical presentation, diagnostic criteria, and management of HH patients.
  • To highlight recent advancements in diagnosing and treating CHI.

Main Methods:

  • Genetic analysis of mutations in eight identified genes (e.g., ABCC8, KCNJ11).
  • Histological characterization into focal and diffuse forms of CHI.
  • Advanced imaging techniques, including 18F-DOPA-PET scans.
  • Laparoscopic surgical interventions.

Main Results:

  • Mutations in ABCC8 and KCNJ11 cause the most severe CHI forms.
  • Improved diagnostic and surgical techniques enhance patient management.
  • HH in adults can stem from insulinomas, pancreatogenous hypoglycaemic syndrome, or post-bariatric surgery complications.

Conclusions:

  • Understanding the genetic etiology and advancements in diagnostics and surgery have significantly improved CHI management.
  • Early identification and meticulous management are vital to prevent neurological sequelae in infants with HH.
  • This review provides a comprehensive overview of CHI's molecular basis, clinical aspects, and therapeutic strategies.

Related Concept Videos

Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
Hypoglycemia01:26

Hypoglycemia

Hypoglycemia is a blood glucose level below 70 mg/dL. It commonly occurs in individuals using insulin or insulin-secreting drugs, but may also arise in non-diabetic conditions. People with type 1 diabetes are at the highest risk because they depend on exogenous insulin. People with type 2 diabetes are also at risk, especially when treated with insulin or medications such as sulfonylureas, which increase insulin release regardless of blood glucose levels. It develops when insulin levels exceed...
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Hyperglycemia01:29

Hyperglycemia

Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...